Tumour Detection
- Name
- Tumour Detection
- Accession Number
- DBCAT002127
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Indium In-111 satumomab pendetide For diagnosis of extrahepatic malignant cancers Capromab pendetide A monoclonal anti-prostate specific membrane antigen antibody used in imaging kits to target radioactive agents to malignant prostate tissue. Technetium Tc-99m arcitumomab For imaging colorectal tumors Technetium Tc-99m tilmanocept A radiopharmaceutical diagnostic imaging agent indicated with or without scintigraphic imaging for lymphatic mapping and guiding sentinel lymph node biopsy. Fluoride ion F-18 A diagnostic radiopharmaceutical agent used as a bone imaging agent to delineate areas of altered osteogenesis. Fludeoxyglucose (18F) A radiopharmaceutical agent used for positron emission tomography (PET) imaging in oncology, cardiology, and neurology. Iobenguane A radiopharmaceutical agent used for the diagnosis of primary and metastatic pheochromocytoma or neuroblastoma. Indium In-111 pentetreotide Indium In 111 pentetreotide (Octreoscan) has been used in trials studying the diagnostic of SARCOIDOSIS, Solid Tumors, and cushing syndrome. Fluciclovine (18F) A radiolabelled L-leucine derivative used to image tumors, especially in the prostate. Edotreotide gallium Ga-68 A radioactive diagnostic agent used in PET scans for somatostatin receptor positive neuroendocrine tumors in adult and pediatric patients. Fluorocholine F-18 A radiopharmaceutical indicated in PET scans of the prostate. Gallium Ga-68 gozetotide A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography. Methionine C-11 Not Annotated FET F-18 FET F-18 is under investigation in clinical trial NCT01756352 (FET-PET for Evaluation of Response of Recurrent GBM to Avastin). - Drugs & Drug Targets